A study to test the safety of a new medicine in children with DMD

• Research type

  Research Study

• Full title

  SMT C1100 - A Phase 1, Open-label, Single and Multiple Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Paediatric Patients with Duchenne Muscular Dystrophy

• IRAS ID

  136017

• Contact name

  Francesco Muntoni

• Contact email

  f.muntoni@ucl.ac.uk

• Sponsor organisation

  Summit Corporation plc

• Eudract number

  2013-002115-99

• REC name

  London - West London & GTAC Research Ethics Committee

• REC reference

  13/LO/1258

• Date of REC Opinion

  31 Oct 2013

• REC opinion

  Further Information Favourable Opinion